Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pulmonology · Asthma and Chronic Obstructive Pulmonary Disease

What Happens If I Have Asthma and COPD Together? Explained

At a Glance

Asthma and COPD are separate lung conditions that can occur together. Because symptoms overlap, doctors use your history, breathing tests, and supportive markers to guide treatment. When asthma is present, treatment includes an inhaled corticosteroid rather than a long-acting beta medicine alone.

Yes, you can have both asthma and COPD at the same time. While doctors previously called this “Asthma-COPD Overlap Syndrome” (ACOS), current medical guidelines treat them as two distinct conditions that can coexist [1]. If you have both, it changes how your daily medications are prescribed to ensure both conditions are managed safely [1].

Overlapping Symptoms: Asthma vs. COPD

Asthma and COPD both make it difficult to breathe, but they usually have different patterns:

  • Asthma typically features variable symptoms that come and go. Flare-ups are often triggered by allergies (a tendency toward allergic disease called atopy), exercise, or viral infections [2]. While it often begins in childhood, it can start in adulthood.
  • COPD (Chronic Obstructive Pulmonary Disease) typically causes persistent, daily symptoms [2]. It is usually an adult-onset condition linked to long-term exposure to cigarette smoke, biomass fumes, or occupational hazards, though it can occasionally affect non-smokers.

The lines between the two can blur. Some patients with longstanding, severe asthma develop persistent airflow limitation that does not fully reverse, looking very similar to COPD [3]. Conversely, some patients with COPD can develop asthma-like features, such as increased allergies [4].

The Challenge of Diagnosis

Because symptoms overlap, there is no single blood test that diagnoses both conditions. Doctors use lung function tests, your medical history, and lab work to build a complete picture.

Breathing Tests (Spirometry)

During a lung function test, your doctor will check your bronchodilator reversibility. This involves measuring your breathing, giving you a quick-relief (rescue) inhaler to quickly open your airways, and measuring again.

While this test is helpful, a “positive” response (meaning the airways open up significantly) cannot reliably separate asthma from COPD on its own [5]. Many patients with pure COPD also show a positive response, so this result must be interpreted alongside your full evaluation [5].

Supportive Biomarkers: Eosinophils and FeNO

Doctors may also look at biomarkers (measurable indicators in your body) for signs of asthma-like inflammation:

  • Eosinophils: A type of white blood cell involved in allergic reactions. Higher levels can suggest an asthma component and help doctors estimate whether you might benefit from corticosteroid inhalers [6].
  • FeNO (Fractional exhaled nitric oxide): A breathing test measuring a gas produced by inflamed airways. High levels can point toward asthma-like inflammation [7].

These tests provide clues, but they are not definitive proof of asthma. Their results can be altered by current steroid treatments, infections, and allergies, and smoking can artificially lower FeNO levels [8][9].

How Coexisting Asthma Changes Your Treatment

The most critical reason to know if you have both conditions is inhaler safety. You should never stop, add, or switch inhalers without consulting your prescriber, but understanding the safety principles can help you have an informed discussion with your care team.

The Danger of LABA Monotherapy

For people who have COPD without asthma, doctors frequently prescribe a LABA (Long-Acting Beta-Agonist) or a LAMA (Long-Acting Muscarinic Antagonist) by themselves to keep the airways open. This is called monotherapy.

However, using a LABA inhaler without an ICS (Inhaled Corticosteroid) is dangerous for people with asthma [10]. Therefore, if asthma is confirmed or strongly suspected alongside your COPD, medical guidelines dictate that you should avoid LABA monotherapy [11].

ICS-Containing Regimens

If you have both conditions, your clinician will generally ensure that an ICS is included in your daily treatment plan [11]. The ICS reduces the specific type of airway inflammation caused by asthma, which helps lower the risk of severe flare-ups [12].

Depending on your symptoms, your doctor might prescribe an ICS and LABA combination inhaler, and they may add a LAMA (known as triple therapy) if you continue to have exacerbations [13][14].

Note on ICS Safety: Inhaled corticosteroids carry risks, including a higher chance of developing pneumonia in some COPD patients, as well as oral thrush and hoarseness [15]. Always rinse your mouth with water and spit after using an ICS controller inhaler to reduce mouth side effects.

Lifestyle and Prevention

Medications work best when paired with healthy habits. Avoiding respiratory triggers, getting support to quit smoking, reducing exposure to occupational dust, and staying up to date on your vaccines are cornerstone measures for preventing dangerous exacerbations [13]. Pulmonary rehabilitation or guided physical activity can also be highly beneficial once your symptoms are controlled.

When to Seek Emergency Care

Breathing flare-ups can escalate quickly. Seek immediate emergency medical help (call 911 or your local emergency number) if you experience:

  • Severe breathlessness at rest or an inability to speak in full sentences
  • Lips or fingertips turning blue or gray
  • Confusion, severe drowsiness, or dizziness
  • Severe chest pain
  • Little or no relief from using your quick-relief (rescue) inhaler

Ask your doctor to help you create a written action plan so you know exactly what to do when your symptoms worsen.

Common questions in this guide

Can a person have asthma and COPD at the same time?
Yes. Asthma and COPD are separate conditions, but they can occur in the same person and cause overlapping symptoms. A clinician uses your medical history and test results to assess each condition.
How do doctors determine whether I have asthma, COPD, or both?
Doctors combine symptom patterns, smoking and exposure history, and spirometry before and after a quick-relief inhaler. A blood count of eosinophils and a breathing test called FeNO can suggest asthma-like inflammation, but no single test confirms both conditions.
How does having asthma change my COPD inhaler treatment?
If asthma is confirmed or strongly suspected, a daily inhaled corticosteroid is generally included. A long-acting beta medicine should not be used by itself in someone with asthma; your prescriber may combine medicines or add another long-acting inhaler if symptoms or flare-ups continue.
What side effects should I watch for with inhaled corticosteroids?
Inhaled corticosteroids can cause hoarseness or oral thrush, and they may increase pneumonia risk in some people with COPD. Rinse your mouth with water and spit it out after each controller dose, and ask your clinician about any new symptoms.
When is an asthma-COPD flare-up an emergency?
Call 911 or your local emergency number for severe breathlessness at rest, inability to speak in full sentences, blue or gray lips or fingertips, confusion, severe drowsiness or dizziness, severe chest pain, or little or no relief from your rescue inhaler. These signs need urgent help rather than waiting for a routine appointment.
What can I do to reduce asthma and COPD flare-ups?
Avoid known breathing triggers and tobacco smoke, seek help quitting smoking, reduce workplace dust or fumes, keep recommended vaccines up to date, and use a written action plan. Pulmonary rehabilitation or guided activity can help once symptoms are controlled.

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap.

    Roman-Rodriguez M, Kaplan A

    International journal of chronic obstructive pulmonary disease 2021; (16()):1709-1715 doi:10.2147/COPD.S300902.

    PMID: 34163155
  2. 2

    Overlapping mechanisms and novel biomarkers define asthma and chronic obstructive pulmonary disease (COPD) as a spectrum of airway diseases.

    Schworer SA, Lee JH, O'Neal WK

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2026; doi:10.1016/j.anai.2026.06.022.

    PMID: 42379419
  3. 3

    Nonlinear associations of the neutrophil-to-lymphocyte ratio and derived neutrophil-to-lymphocyte ratio with asthma-COPD overlap prevalence: a cross-sectional study.

    Jin R, Wang S, Zhang J, et al.

    Frontiers in medicine 2026; (13()):1950041 doi:10.3389/fmed.2026.1950041.

    PMID: 42871116
  4. 4

    Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.

    Suzuki M, Makita H, Konno S, et al.

    American journal of respiratory and critical care medicine 2016; (194(11)):1358-1365 doi:10.1164/rccm.201602-0353OC.

    PMID: 27224255
  5. 5

    Bronchodilator reversibility in asthma and COPD: findings from three large population studies.

    Janson C, Malinovschi A, Amaral AFS, et al.

    The European respiratory journal 2019; (54(3)) doi:10.1183/13993003.00561-2019.

    PMID: 31221806
  6. 6

    Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.

    Li A, Chan HP, Gan PXL, et al.

    The Korean journal of internal medicine 2021; (36(6)):1305-1319 doi:10.3904/kjim.2021.180.

    PMID: 34634855
  7. 7

    Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome.

    Miskoff JA, Dewan A, Chaudhri M

    Cureus 2019; (11(6)):e4864 doi:10.7759/cureus.4864.

    PMID: 31417809
  8. 8

    Differential diagnosis of asthma and COPD: Established and emerging biomarkers and technologies.

    Cabot J, Busquets X, Soriano JB

    Respiratory medicine 2026; (262()):109124 doi:10.1016/j.rmed.2026.109124.

    PMID: 42665061
  9. 9

    Different Relationships between FENO and COPD Characteristics in Smokers and Ex-Smokers.

    Högman M, Thornadtsson A, Bröms K, et al.

    COPD 2019; (16(3-4)):227-233 doi:10.1080/15412555.2019.1638355.

    PMID: 31357875
  10. 10

    The asthma COPD overlap syndrome (ACOS).

    Bujarski S, Parulekar AD, Sharafkhaneh A, Hanania NA

    Current allergy and asthma reports 2015; (15(3)):509 doi:10.1007/s11882-014-0509-6.

    PMID: 25712010
  11. 11

    Management of asthma COPD overlap.

    Maselli DJ, Hanania NA

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(4)):335-344 doi:10.1016/j.anai.2019.07.021.

    PMID: 31376487
  12. 12

    Comparison of clinical outcome of COPD with asthma-like feature with different inhalation therapies: a real-world study in the prospective RealDTC cohort.

    Lin L, Cheng W, Song Q, et al.

    BMC pulmonary medicine 2025; (25(1)):294 doi:10.1186/s12890-025-03767-x.

    PMID: 40604630
  13. 13

    Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence.

    Hines KL, Peebles RS

    Current allergy and asthma reports 2017; (17(3)):15 doi:10.1007/s11882-017-0683-4.

    PMID: 28283854
  14. 14

    A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.

    Park SY, Kim S, Kim JH, et al.

    The journal of allergy and clinical immunology. In practice 2021; (9(3)):1304-1311.e2 doi:10.1016/j.jaip.2020.09.066.

    PMID: 33184024
  15. 15

    Inhaled corticosteroids in COPD: friend or foe?

    Agusti A, Fabbri LM, Singh D, et al.

    The European respiratory journal 2018; (52(6)) doi:10.1183/13993003.01219-2018.

    PMID: 30190269

This page explains how asthma and COPD can coexist and why inhaler choices matter for informational purposes only; it does not constitute medical advice. Do not start, stop, or switch inhalers without guidance from your prescriber.